J = 7.1); 1.37 (3H, t, J = 7.1); 0.94 (18H, s); 0.09 (12H, s).
13C NMR (100 MHz, CDCl3): d 166.5, 156.1, 150.16, 149.26,
146.4, 134.5, 129.9, 129.6, 126.2, 122.1, 61.9, 61.2, 26.7, 19.1,
15.1, ꢁ4.5. HRMS (MALDI-TOF): calc. for C30H45NO9Si2
642.2525 [M + Na+], found 642.2482.
Mp 100 1C (decomp.). 1H NMR (200 MHz, CDCl3): d 8.16
(4H, d, J = 8.2); 7.66 (2H, s); 7.56 (4H, d, J = 8.2); 5.16
(4H, s); 4.40 (2H, q, J = 6.8); 3.7–3.3 (4H, m); 3.2 (3H, s); 2.94
(3H, s); 1.41 (9H, s); 1.27 (3H, t, J = 6.8). 13C NMR
(100 MHz, CDCl3): d 166.7, 158.2, 154.8, 146.5, 144.6,
135.1, 133.2, 131.6, 126.9, 119.6, 82.7, 63.7, 63.4, 49.1, 48.5,
38.2, 37.5, 30.4, 16.247. HRMS (MALDI-TOF): calc. for
C35H40N6O14 791.2494 [M + Na]+, found 791.2470.
Compound 8. Compound 7 (1.17 g, 1.92 mmol) was dissolved
in 30 ml DMF and mono-Boc-protected N,N0-dimethyl-
ethylenediamine (543 mg, 2.88 mmol) was added. The reaction
was stirred in room temperature and was monitored by TLC
(EtOAc–hexane = 1 : 3). After 1 h the reaction was complete,
the solvent was removed under reduced pressure, and the
crude product was purified by using column chromatography
on silica gel (EtOAc–hexane = 15 : 85) to give compound 8
(835 mg, 65%) as a viscous oil.1
1H NMR (200 MHz, CDCl3): d 8.10 (2H, s); 4.64 (4H, s);
4.32 (2H, q, J = 7.0); 3.55–3.42 (4H, m); 3.12–3.00 (3H, m);
2.92–2.89 (3H, m); 1.53–1.45 (9H, m); 1.38 (3H, t, J = 7.0); 0.9
(18H, s); 0.07 (12H, s). 13C NMR (100 MHz, CDCl3) d 167.0,
153.7, 149.4, 135.1, 128.8, 126.8, 116.3, 80.6, 61.6, 60.2, 48.1,
47.1, 36.2, 35.9, 29.2, 26.6, 19.1, 14.9, ꢁ4.5. HRMS (MALDI-
TOF): calc. for C33H60N2O8Si2 691.3780 [M + Na+], found
691.374.
Compound 10. Compound 9 (103 mg, 0.234 mmol) was
dissolved in 10 ml dry THF and the solution was cooled to
0 1C. Then DIPEA (0.33 ml, 1.872 mmol), was added followed
by PNP-chloroformate (283 mg, 1.4 mmol) and a catalytic
amount of pyridine. The reaction was stirred in room tem-
perature and monitored by TLC (EtOAc–hexane = 1 : 1).
After 15 min the reaction was completed and the solvent was
removed under reduced pressure. The crude product was
diluted with EtOAc and washed with saturated NH4Cl and
with saturated NaHCO3 solutions. The organic layer was
dried over magnesium sulfate and the solvent was removed
under reduced pressure. The crude product was purified by
using column chromatography on silica gel (EtOAc–hexane =
1 : 1) to give compound 10 (160 mg, 89%) as a white solid.
Mp 100 1C (decomp.). 1H NMR (400 MHz, CDCl3): d
8.24–8.20 (6H, m); 7.36 (4H, d, J = 7.0); 5.31 (4H, s); 4.38
(2H, q, J = 7.0); 3.60–3.45 (4H, m); 3.20–3.02 (3H, m);
2.94–2.85 (3H, m); 1.43–1.41 (9H, m); 1.38 (3H, t, J = 7.0).
13C NMR (100 MHz, CDCl3): d 165.8, 156.2, 154.1, 153.0,
152.5, 152.4, 146.3, 132.0, 129.6, 126.1, 122.8, 122.6, 80.7, 66.4,
62.3, 48.3, 46.9, 35.6, 32.3, 29.1, 14.9. HRMS (MALDI-TOF):
calc. for C35H38N4O16 793.2175 [M + Na+], found 793.2148.
Compound 9. Compound 8 (800 mg, 1.19 mmol) was
dissolved in 10 ml MeOH and Amberlyst-15 was added. The
reaction was stirred in room temperature for 2 h and was
monitored by TLC (EtOAc–hexane = 3 : 1). After comple-
tion, the Amberlyst-15 was filtered out and the solvent was
removed under reduced pressure. The crude product
was purified by using column chromatography on silica gel
(EtOAc–hexane = 9 : 1) to give compound 9 (455 mg, 86%) as
a white powder.
Mp 100 1C (decomp.). 1H NMR (200 MHz, CDCl3): d 8.08
(2H, s); 4.61 (4H, s); 4.36 (2H, q, J = 7.1); 3.7–3.4 (4H, m);
3.17 (3H, s); 3.04 (3H, s); 2.94 (3H, s); 1.48–1.42 (9H, m); 1.35
(3H, t, J = 7.1). 13C NMR (100 MHz, CDCl3): d 166.6, 156.8,
155.6, 155.4, 135.1, 131.5, 129.2, 81.2, 61.9, 61.0, 47.5, 47.1,
36.9, 35.8, 29.1, 15.1. HRMS (MALDI-TOF): calc. for
C21H32N2O8 463.2051 [M + Na+], found 463.2087.
Dendron 4. Compound 2 (250 mg, 0.32 mmol) was dissolved
in 1 ml TFA and stirred for a few minutes, the excess of acid
was removed under reduced pressure and the crude amine salt
was dissolved in 2 ml DMF. Compound 10 (100 mg, 0.13
mmol) was added followed by the addition of 1 ml Et3N. The
reaction mixture was stirred in room temperature and
monitored by TLC (EtOAc–hexane = 75 : 25). After 2 h the
reaction was completed and the solvent was removed under
reduced pressure. The crude product was purified by using
column chromatography on silica gel (EtOAc–hexane = 70 : 30)
to give compound 4 (189 mg, 80%) as a yellowish powder.
Mp 100 1C (decomp.). 1H NMR (200 MHz, CDCl3): d
8.20–8.06 (14H, m); 7.48 (6H, m); 5.13 (12H, m); 4.38 (6H, m);
3.61–2.61 (30H, m); 1.40 (9H, m); 1.31–1.23 (9H, m). 13C
NMR (100 MHz, CDCl3): d 167.13, 154.75, 146.68, 144.49,
131.9, 131.69, 130.39, 126.84, 119.59, 64.15, 63.43, 48.67,
46.94, 36.75, 33.35, 30.19, 22.94. HRMS (MALDI-TOF): calc.
for C83H92N14O34 1851.5792 [M + Na]+, found 1851.5638.
Dendron 2. p-Nitroaniline (342 mg, 2.48 mmol) was dis-
solved in 20 ml of dry THF and a solution of 20% phosgene in
toluene (2.6 ml, 4.956 mmol) was added. The reaction was
refluxed for 2 h and monitored by 1H NMR (200 MHz,
DMSO). After the isocyanate derivative was observed, the
solvent was removed under reduced pressure. A solution of
compound 9 (364 mg, 0.826 mmol) in 10 ml THF followed by
Et3N (0.42 ml, 3 mmol) was added to the residue. The reaction
was stirred in room temperature and was monitored by TLC
(EtOAc–hexane = 1 : 1). After 1 h the reaction was completed
and the solvent was removed under reduced pressure. The
crude product was diluted with DCM, salts were filtered out
and the crude was washed again with DCM. The organic layer
was dried over magnesium sulfate and the solvent was re-
moved under reduced pressure. The crude product was pur-
ified by using column chromatography on silica gel
(EtOAc–hexane = 2 : 3) to give compound 2 (573 mg, 90%)
as a yellow powder.
Dendron activation protocol
Dendrons 1–4 were deprotected with trifluoroacetic acid
(TFA) and the corresponding salts were used for the prepara-
tion of 10.0 mM stock solutions in DMSO. The stock solu-
tions were diluted with MeOH and 10% triethylamine to give
final concentrations of 500 mM of dendrons 1–4. The release of
p-nitroaniline from the dendron stock solutions was moni-
tored by an HPLC assay using C-18 reverse-phase analytical
ꢀc
This journal is the Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2007
New J. Chem., 2007, 31, 1307–1312 | 1311